REQUEST A DEMO
Total
USD $0.00
Search more companies

Wuhan National Pharmaceutical Technology Co.Ltd. (China)

Main Activities: Engine, Turbine, and Power Transmission Equipment Manufacturing | Metal and Mineral (except Petroleum) Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Wuhan National Pharmaceutical Technology Co.Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Hubei Huarong Holding Co., Ltd. is a key supported enterprise in Wuhan, located in the East Lake High-tech Development Zone. In 2013, the company sold all of its assets and business related to pharmaceutical production and retail. Currently, its main business is steel trading. With the support of its major shareholder, the company received a 75% equity stake in Shanghai Aobai Internal Combustion Engine Parts Co., Ltd., a related party, and successfully operated the business. Additionally, the major shareholder relieved the company of some of its debts, significantly improving its asset situation. On September 19, 2020, the company changed its name from "Hubei Yangfan Holdings Co., Ltd." to "Hubei Huarong Holdings Co., Ltd."

Headquarters
Building 3, Kaide Center, Shendun 1st Road, Hongshan District, Wuhan City, Hubei Province, 1101
Wuhan; Hubei; Postal Code: 430075

Contact Details: Purchase the Wuhan National Pharmaceutical Technology Co.Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Wuhan National Pharmaceutical Technology Co.Ltd. report to view the information.
Outstanding Shares:
Purchase the Wuhan National Pharmaceutical Technology Co.Ltd. report to view the information.
Registered Capital:
Purchase the Wuhan National Pharmaceutical Technology Co.Ltd. report to view the information.
Financial Auditors:
Purchase the Wuhan National Pharmaceutical Technology Co.Ltd. report to view the information.
Incorporation Date:
November 20, 1997
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
19.5%
Purchase this report to view the information.
17.5%
Purchase this report to view the information.
12.46%
Purchase this report to view the information.
4.09%
Purchase this report to view the information.
1.36%
Subsidiaries
Zhejiang Zhuangchen Construction Technology Co., Ltd.
51%
Guangdong Zhuangchen Construction Technology Co., Ltd.
48.96%
Company Performance
Financial values in the chart are available after Wuhan National Pharmaceutical Technology Co.Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-14.96%
Total operating revenue
-14.96%
Operating profit (EBIT)
66.6%
Net Profit (Loss) for the Period
61.47%
Total assets
1.92%
Total equity
-14.93%
Operating Profit Margin (ROS)
0.84%
Net Profit Margin
1.02%
Return on Equity (ROE)
2.07%
Debt to Equity Ratio
58.31%
Quick Ratio
-0.19%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?